Investigations of the supercoil-selective DNA binding of wild type p53 suggest a novel mechanism for controlling p53 function

被引:37
|
作者
Fojta, M
Pivonkova, H
Brazdova, M
Nemcova, K
Palecek, J
Vojtesek, B
机构
[1] Acad Sci Czech Republ, Inst Biophys, Lab Biophys Chem & Mol Oncol, CZ-61265 Brno, Czech Republic
[2] Univ Hamburg, Dept Tumor Virol, Heinrich Pette Inst Expt Virol & Immunol, Hamburg, Germany
[3] Univ Sussex, Genome Damage & Stabil Ctr, Brighton, E Sussex, England
[4] Masaryk Mem Canc Inst, Brno, Czech Republic
来源
EUROPEAN JOURNAL OF BIOCHEMISTRY | 2004年 / 271卷 / 19期
关键词
monoclonal antibodies; p53; latency; redox state; supercoil-selective DNA binding; tumor suppressor protein p53;
D O I
10.1111/j.1432-1033.2004.04323.x
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The tumor suppressor protein, p53, selectively binds to supercoiled (sc) DNA lacking the specific p53 consensus binding sequence (p53CON). Using p53 deletion mutants, we have previously shown that the p53 C-terminal DNA-binding site (CTDBS) is critical for this binding. Here we studied supercoil-selective binding of bacterially expressed full-length p53 using modulation of activity of the p53 DNA-binding domains by oxidation of cysteine residues (to preclude binding within the p53 core domain) and/or by antibodies mapping to epitopes at the protein C-terminus (to block binding within the CTDBS). In the absence of antibody, reduced p53 preferentially bound scDNA lacking p53CON in the presence of 3 kb linear plasmid DNAs or 20 mer oligonucleotides, both containing and lacking the p53CON. Blocking the CTDBS with antibody caused reduced p53 to bind equally to sc and linear or relaxed circular DNA lacking p53CON, but with a high preference for the p53CON. The same immune complex of oxidized p53 failed to bind DNA, while oxidized p53 in the absence of antibody restored selective scDNA binding. Antibodies mapping outside the CTDBS did not prevent p53 supercoil-selective (SCS) binding. These data indicate that the CTDBS is primarily responsible for p53 SCS binding. In the absence of the SCS binding, p53 binds sc or linear (relaxed) DNA via the p53 core domain and exhibits strong sequence-specific binding. Our results support a hypothesis that alterations to DNA topology may be a component of the complex cellular regulatory mechanisms that control the switch between latent and active p53 following cellular stress.
引用
收藏
页码:3865 / 3876
页数:12
相关论文
共 50 条
  • [21] Wild type p53 inhibits endothelial cell function
    Riccioni, T
    Cirielli, C
    Passaniti, A
    Capogrossi, MC
    CIRCULATION, 1996, 94 (08) : 611 - 611
  • [22] Altered P53 conformation: A novel mechanism of wild-type p53 functional inactivation in a model for early human breast cancer
    Shekhar, PVM
    Welte, R
    Christman, JK
    Wang, H
    Werdell, J
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1997, 11 (05) : 1087 - 1094
  • [23] Oligomerization of BAK by p53 utilizes conserved residues of the p53 DNA binding domain
    Pietsch, E. Christine
    Perchiniak, Erin
    Canutescu, Adrian A.
    Wang, Guoli
    Dunbrack, Roland L.
    Murphy, Maureen E.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (30) : 21294 - 21304
  • [24] Wild type and mutant p53 functions
    Lozano, Guillermina
    CANCER SCIENCE, 2022, 113 : 1227 - 1227
  • [25] Diverse p53/DNA binding modes expand the repertoire of p53 response elements
    Vyas, Pratik
    Beno, Itai
    Xi, Zhiqun
    Stein, Yan
    Golovenko, Dmitrij
    Kessler, Naama
    Rotter, Varda
    Shakked, Zippora
    Haran, Tali E.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (40) : 10624 - 10629
  • [26] EGFR SUPPRESSES p53 FUNCTION THROUGH DNA-PKcs BINDING TO p53: NOVEL CROSSTALK BETWEEN EGFR AND TP53 IN GLIOBLASTOMA
    Ding, Jie
    Li, Xiaolong
    Zhang, Chen
    Gao, Feng
    Wu, Shaofang
    Wasylishen, Amanda
    Baggerly, Keith
    Lozano, Guillermina
    Koul, Dimpy
    Yung, Alfred
    NEURO-ONCOLOGY, 2019, 21 : 40 - 40
  • [27] REGULATION OF THE SPECIFIC DNA-BINDING FUNCTION OF P53
    HUPP, TR
    MEEK, DW
    MIDGLEY, CA
    LANE, DP
    CELL, 1992, 71 (05) : 875 - 886
  • [28] SCH529074, a Small Molecule Activator of Mutant p53, Which Binds p53 DNA Binding Domain (DBD), Restores Growth-suppressive Function to Mutant p53 and Interrupts HDM2-mediated Ubiquitination of Wild Type p53
    Demma, Mark
    Maxwell, Eugene
    Ramos, Robert
    Liang, Lianzhu
    Li, Cheng
    Hesk, David
    Rossman, Randall
    Mallams, Alan
    Doll, Ronald
    Liu, Ming
    Seidel-Dugan, Cynthia
    Bishop, W. Robert
    Dasmahapatra, Bimalendu
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2010, 285 (14) : 10198 - 10212
  • [29] The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 association
    Yoichi Nagata
    Tadashi Anan
    Tetsuo Yoshida
    Tamio Mizukami
    Yoichi Taya
    Toshiyoshi Fujiwara
    Hirohisa Kato
    Hideyuki Saya
    Mitsuyoshi Nakao
    Oncogene, 1999, 18 : 6037 - 6049
  • [30] The stabilization mechanism of mutant-type p53 by impaired ubiquitination: the loss of wild-type p53 function and the hsp90 association
    Nagata, Y
    Anan, T
    Yoshida, T
    Mizukami, T
    Taya, Y
    Fujiwara, T
    Kato, H
    Saya, H
    Nakao, M
    ONCOGENE, 1999, 18 (44) : 6037 - 6049